In comparison, no recurrence of TC-1 tumor growth was observed in mice treated with cisplatin, AnxA5-E7, and anti-PD-1, anti-PD-L1, or anti-TIM-3 (Fig. 7b). Here, HAVCR2 is linked to neoplasm.